DDReg Pharma, a leading global provider of regulatory affairs and pharmacovigilance solutions, today announced the expansion of its expert Regulatory Medical Writing Services. The enhanced offering provides pharmaceutical and biotechnology companies with high-quality, compliant documentation that supports the entire product lifecycle, from early clinical development through post-market surveillance.
DDReg’s dedicated medical writing team leverages over 16 years of industry experience to address the complex challenges of documenting clinical data and adhering to evolving global regulatory guidelines. The service is designed to ensure clarity, scientific accuracy, and alignment with regulatory expectations, facilitating efficient review cycles and successful product approvals.
The comprehensive suite of services includes the preparation of essential documentation for regulatory filings and ongoing compliance, such as:
- Clinical and Nonclinical Sections of the eCTD (Modules 2.4 to 2.7).
- Core Clinical Documentation: Study Protocols, Investigator’s Brochures (IBs), and Clinical Study Reports (CSRs).
- Safety and Aggregate Reports: Development Safety Update Reports (DSURs), Periodic Safety Update Reports (PSURs), and Periodic Benefit-Risk Evaluation Reports (PBRERs).
- Product Information: Preparation of Product Labels (SPC/PIL/PIs) and Biowaiver Justifications.
“In today’s global regulatory landscape, the quality and precision of medical documentation are non-negotiable,” said a spokesperson for DDReg Pharma. “Our focus on robust processes and deep understanding of the CTD structure allows us to deliver submission-ready content that reduces regulatory risk and accelerates time-to-market for our clients worldwide.”
DDReg Pharma is committed to integrating subject-matter expertise with a client-focused approach, ensuring documentation not only meets stringent standards but also effectively communicates risk and efficacy to regulatory bodies.
About DDReg Pharma:
DDReg Pharma is a quality-driven global regulatory and life Sciences consultancy firm, offering strategic solutions across the product lifecycle for pharmaceutical, biotech, and medical device organizations. With a global reach and expertise in key regulatory markets, DDReg helps clients navigate complex compliance requirements to achieve clinical success and regulatory excellence.





